0.8038
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Brooklyn ImmunoTherapeutics Inc | BTX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
 |
|
|---|---|---|---|---|
| 0.00 | 0.0% | 0.8038 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.8038 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 0.70 - 10.00 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 0.8038 | USD |
Period:
Draw Mode:
Brooklyn ImmunoTherapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 46.18M | 57.45M | 51.55M | $ - | $ - | -2.58 | -0.30 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | 2.05M | 10.70% |
Brooklyn ImmunoTherapeut... News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BTX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.8852 | 0.9439 | 0.70 | 0.7790807 | 797,940 | -0.0814 | -9.2% |
| 1 Month | 1.46 | 1.4688 | 0.70 | 0.9846874 | 538,817 | -0.6562 | -44.95% |
| 3 Months | 2.20 | 2.38 | 0.70 | 1.56 | 452,320 | -1.40 | -63.46% |
| 6 Months | 7.71 | 7.95 | 0.70 | 3.15 | 474,670 | -6.91 | -89.57% |
| 1 Year | 9.86 | 10.00 | 0.70 | 3.57 | 481,324 | -9.06 | -91.85% |
| 3 Years | 9.86 | 10.00 | 0.70 | 3.57 | 481,324 | -9.06 | -91.85% |
| 5 Years | 9.86 | 10.00 | 0.70 | 3.57 | 481,324 | -9.06 | -91.85% |
Brooklyn ImmunoTherapeut... Description
| Brooklyn ImmunoTherapeutics Inc is a clinical-stage biopharmaceutical company. It is developing IRX-2, a novel hd-IL-2 -based therapy, to treat patients with cancer. IRX-2 delivers hd-IL-2 and other key cytokines to potentially restore immune function in the tumor microenvironment, enabling the immune system to attack cancer cells. |